High Prevalence of Infectious Disease Is Accelerating the Growth of the Conjugate Vaccine Market
A conjugate vaccine can be defined as a kind of vaccine that combines a pair of proteins that stimulate the immune system to produce antibodies against a specific virus or bacteria. These shots are made from a combination of a common virus-like measles and a virus that cause the common cold, like the swine flu. A conjugate vaccine has become one of the most efficient and strongest forms of prevention and treatment against these types of dangerous viruses. Scientists have been trying for several years to develop a vaccine that would be able to provide complete protection against all known viruses The growing prevalence of the infectious disease is one of the prime factors driving the growth of the conjugate vaccine market . According to the World Health Organization, every year, 10 million people fall ill with tuberculosis (TB). Despite being a preventable and curable disease, 1.5 million people die from tuberculosis each year – making it the world’s top infectious killer. Most of t